U.S. Healthcare Consumables Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Healthcare Consumables Market 

5.1. COVID-19 Landscape: US Healthcare Consumables Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Healthcare Consumables Market, By Product Type

8.1. US Healthcare Consumables Market Revenue and Volume, by Product Type, 2024-2033

8.1.1 Wound care Consumables

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Diagnostic Consumables

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Respiratory Supplies

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Drug Delivery Products

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Dialysis Consumables

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Sterilization Consumables

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Incontinence Products

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

8.1.8. Disposable Gloves

8.1.8.1. Market Revenue and Volume Forecast (2021-2033)

8.1.9. Disposable Masks

8.1.9.1. Market Revenue and Volume Forecast (2021-2033)

8.1.10. Hands Sanitizer

8.1.10.1. Market Revenue and Volume Forecast (2021-2033)

8.1.11. Others

8.1.11.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. US Healthcare Consumables Market, By Raw Materials

9.1. US Healthcare Consumables Market Revenue and Volume, by Raw Materials, 2024-2033

9.1.1. Rubber

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Non-woven Materials

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Glass

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Metals

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Plastic Resin

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

9.1.6. Paper

9.1.6.1. Market Revenue and Volume Forecast (2021-2033)

9.1.7. Others

9.1.7.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. US Healthcare Consumables Market, By End User 

10.1. US Healthcare Consumables Market Revenue and Volume, by End User, 2024-2033

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Clinics/physician office

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. US Healthcare Consumables Market and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Raw Materials (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by End User (2021-2033)

Chapter 12. Company Profiles

12.1. Boston Scientific Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Avanos Medical, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Baxter International, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Thermo Fisher Scientific, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. 3M

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Johnson & Johnson

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Medtronic

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Cardinal Health, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. B. Braun Melsungen AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. BD

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms